featured
Topical Dorzolamide–Timolol With Intravitreous Anti-VEGF for Neovascular Age-Related Macular Degeneration
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Ophthalmology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Topical Dorzolamide-Timolol With Intravitreous Anti-Vascular Endothelial Growth Factor for Neovascular Age-Related Macular Degeneration
JAMA Ophthalmol 2016 Feb 25;[EPub Ahead of Print], J Sridhar, J Hsu, A Shahlaee, SJ Garg, MJ Spirn, MS Fineman, J VanderFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.